Raymond James Financial
VTAK icon

Raymond James Financial’s Catheter Precision VTAK Stock Holding History

Raymond James Financial’s Portfolio VTAK Stock Details VTAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-48
Closed -$220 – 6753
2025
Q2 		$220 Buy
+48
New +$260 ﹤0.01% 6773

Other funds holding VTAK

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $7.43B AUM 24.49% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

Raymond James Financial's VTAK Position: Q3 2025 in Review

Raymond James Financial sold out of Catheter Precision (VTAK) in Q3 2025, closing a stake of 48 shares — an estimated $220 sold.

Raymond James Financial first reported a position in VTAK in Q2 2025 and held it in 1 quarter. The position peaked at $220 in Q2 2025. 3 funds tracked by Wall St. Rank hold VTAK as of Q3 2025.

  • Raymond James Financial reported no remaining Catheter Precision position as of Q3 2025 after selling out during the quarter.
  • Raymond James Financial sold 48 Catheter Precision shares in Q3 2025, an estimated $220.
  • Raymond James Financial first reported a position in Catheter Precision in Q2 2025 and held it in 1 quarter.
  • Raymond James Financial's Catheter Precision position peaked at $220 in Q2 2025.
  • 3 funds tracked by Wall St. Rank held Catheter Precision as of Q3 2025.

Based on Raymond James Financial's 13F filing for Q3 2025, filed 14 Nov 2025.